Trial Information
Inclusion Criteria:
- HBV-positive patients
Exclusion Criteria:
- HBV-negative patients
Type of Study:
Interventional
Study Design:
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science
Outcome Measure:
cytokine gene polymorphism
Outcome Time Frame:
years
Principal Investigator
Jen-Eing Jeng, M.D.
Investigator Role:
Principal Investigator
Investigator Affiliation:
Assistant Professor of Clinical Laboratory
Authority:
Taiwan: Department of Health
Study ID:
KMUH-IRB-940189
NCT ID:
NCT00629668
Start Date:
January 2007
Completion Date:
December 2007
Related Keywords:
- Chronic Liver Disease
- Hepatocellular Carcinoma
- Carcinoma
- Liver Diseases
- Carcinoma, Hepatocellular